CTLA4 and lymphoma: However, data from a cord blood-humanized mouse model suggest that both PD-1 and CTLA-4 are expressed on T cells and that PD-1/CTLA-4 blockade increases T cell infiltration of tumors, promotes T cell activation, and eventually leads to a drastic reduction of the size of EBV-induced lymphomas [70].